Deroy & Devereaux Private Investment Counsel Inc. Lowers Stake in Teradyne, Inc. $TER

Deroy & Devereaux Private Investment Counsel Inc. cut its holdings in shares of Teradyne, Inc. (NASDAQ:TER) by 30.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 114,066 shares of the company’s stock after selling 51,007 shares during the quarter. Teradyne makes up approximately 2.3% of Deroy & Devereaux Private Investment Counsel Inc.’s portfolio, making the stock its 4th largest holding. Deroy & Devereaux Private Investment Counsel Inc.’s holdings in Teradyne were worth $55,190,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of TER. State Street Corp raised its position in shares of Teradyne by 0.9% in the fourth quarter. State Street Corp now owns 7,078,635 shares of the company’s stock valued at $1,370,141,000 after purchasing an additional 60,986 shares during the period. Ameriprise Financial Inc. boosted its holdings in Teradyne by 3.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 4,920,100 shares of the company’s stock worth $442,413,000 after buying an additional 143,058 shares during the period. Price T Rowe Associates Inc. MD grew its position in shares of Teradyne by 18.6% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 4,203,546 shares of the company’s stock valued at $813,640,000 after purchasing an additional 659,273 shares in the last quarter. Invesco Ltd. raised its stake in shares of Teradyne by 3.5% during the 3rd quarter. Invesco Ltd. now owns 2,959,330 shares of the company’s stock valued at $407,322,000 after purchasing an additional 99,864 shares during the period. Finally, Morgan Stanley lifted its holdings in Teradyne by 1.9% during the 4th quarter. Morgan Stanley now owns 2,442,014 shares of the company’s stock worth $472,677,000 after purchasing an additional 45,089 shares in the last quarter. Hedge funds and other institutional investors own 99.77% of the company’s stock.

Analysts Set New Price Targets

A number of research firms recently weighed in on TER. Zacks Research raised shares of Teradyne from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 12th. The Goldman Sachs Group reaffirmed a “buy” rating and set a $465.00 price objective on shares of Teradyne in a research note on Tuesday, July 28th. UBS Group lifted their target price on shares of Teradyne from $440.00 to $500.00 and gave the stock a “buy” rating in a research note on Monday, July 20th. Robert W. Baird set a $420.00 price target on Teradyne in a research report on Thursday, July 30th. Finally, JPMorgan Chase & Co. raised shares of Teradyne from a “neutral” rating to an “overweight” rating and set a $400.00 target price for the company in a research report on Thursday, April 30th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $396.80.

Insider Buying and Selling

In other Teradyne news, insider Shannon John Poulin sold 1,008 shares of the company’s stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $345.37, for a total transaction of $348,132.96. Following the completion of the sale, the insider directly owned 15,066 shares of the company’s stock, valued at approximately $5,203,344.42. This represents a 6.27% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Gregory Stephen Smith sold 4,000 shares of the firm’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $423.03, for a total transaction of $1,692,120.00. Following the sale, the chief executive officer owned 120,470 shares in the company, valued at approximately $50,962,424.10. The trade was a 3.21% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 5,664 shares of company stock worth $2,273,133. 0.19% of the stock is currently owned by insiders.

Teradyne Trading Up 1.9%

NASDAQ TER opened at $410.52 on Friday. The stock has a market cap of $64.18 billion, a P/E ratio of 56.31, a P/E/G ratio of 0.81 and a beta of 1.78. The stock’s fifty day moving average price is $383.05 and its 200-day moving average price is $347.89. Teradyne, Inc. has a 12 month low of $106.30 and a 12 month high of $487.91.

Teradyne (NASDAQ:TER) last released its quarterly earnings data on Wednesday, July 29th. The company reported $2.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.09 by $0.38. The business had revenue of $1.33 billion for the quarter, compared to analysts’ expectations of $1.22 billion. Teradyne had a return on equity of 39.93% and a net margin of 25.77%.The firm’s quarterly revenue was up 103.9% on a year-over-year basis. During the same period in the prior year, the firm posted $0.57 EPS. As a group, analysts forecast that Teradyne, Inc. will post 9.1 earnings per share for the current fiscal year.

Teradyne Profile

Teradyne, Inc is a global supplier of automatic test equipment and related services principally used to test semiconductors, wireless products and complex electronic systems. Founded in 1960, the company is headquartered in North Reading, Massachusetts, and has a long history of developing capital equipment and software that help semiconductor manufacturers, electronics OEMs and contract manufacturers validate product performance and reliability during design and production.

The company’s product portfolio centers on automatic test equipment (ATE) and system-level test solutions that address chip- and board-level validation, burn-in and reliability screening.